二级教授，主任医师，博士研究生导师，温州医科大学附属眼视光医院党委委员、副院长，温州医科大学青光眼研究所所长,浙江省钱江学者特聘教授，万人计划科技创新领军人，浙江省卫生高层次创新人才，浙江省151第一层次人才，浙江省高校创新领军人才(2020)，美国霍普金斯大学博士后。

国际亚太眼科会防盲委员会常务委员兼秘书，中华医学会眼科学分会专家会员，中华医学会眼科学会青光眼学组委员，浙江省青光眼学组组长，中国医师协会眼科医师分会青光眼专业委员会青光眼学组委员，中国医师协会循证医学专委会副主委，循证眼与视觉科学学组组长。

2024浙江省科技进步二等奖第一完成人，主持国家重点研发、国自然等课题10余项，发明穿透性Schlemm成形术，提出跨晶状体压力差学说;在Lancet GH,Ophthalmology, IOVS、eLife,等SCI 权威期刊发表论文430余篇，总被引7000+次，H指数42，获国内外发明专利21项。

MD, PhD: Chief Physician, Doctoral Supervisor, and Postdoctoral Alumnus of Johns Hopkins University.

• Leadership: Deputy Director of the National Clinical Research Center for Ocular and Optometric Diseases; Director of the Glaucoma Center and Glaucoma Institute at Wenzhou Medical University.

• Professional Service: Expert Member of the Chinese Medical Association (CMA) Ophthalmology Branch.

• Research Funding: Principal Investigator for over 10 major projects, including the National Key Research and Development Program of China and the National Natural Science Foundation of China (NSFC).

• Key Innovations: Inventor of Penetrating Canaloplasty and proposer of the Trans-lens Pressure Difference Theory.

• Academic Impact: Published 430+ SCI papers in Lancet GH, Ophthalmology, and eLife; H-index: 42; 7,000+ total citations. Holder of 21 domestic and international invention patents.